መነሻ › ኖን-ስማል ሴል የሳንባ ካንሰር › Washington › Tacoma
በTacoma፣ WA ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ 20 ጥናቶች በTacoma እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · 26 ማይል ርቀት
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · 8 ማይል ርቀት
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · 8 ማይል ርቀት
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 ማይል ርቀት
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 ማይል ርቀት
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Vista Oncology Inc PS, Olympia · 26 ማይል ርቀት
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Vista Oncology, Olympia · 26 ማይል ርቀት
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- American Oncology Network Vista Oncology Division-West office, Olympia · 26 ማይል ርቀት
- American Oncology Network Vista Oncology Division-East office, Olympia · 26 ማይል ርቀት
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Northwest Medical Specialties (NWMS), Tacoma
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Local Institution - 0499, Lacey · 23 ማይል ርቀት
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Tacoma
- Research Site, Olympia · 26 ማይል ርቀት
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · 26 ማይል ርቀት
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · 8 ማይል ርቀት
- እና 3 ተጨማሪ
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · 8 ማይል ርቀት
- MultiCare Regional Cancer Center, Puyallup · 8 ማይል ርቀት
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- USA09-0, Puyallup · 8 ማይል ርቀት
BostonGene and Exigent Genomic INsight Study
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Northwest Medical Specialities, Puyallup · 8 ማይል ርቀት
በሌሎች ከተሞች ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ጥናቶች
- Houston, TX145 ጥናቶች
- New York City, NY121 ጥናቶች
- Arlington, VA104 ጥናቶች
- Nashville, TN97 ጥናቶች
- Boston, MA90 ጥናቶች
- Los Angeles, CA87 ጥናቶች
- St. Louis, MO73 ጥናቶች
- Chicago, IL61 ጥናቶች
- Baltimore, MD60 ጥናቶች
- San Antonio, TX59 ጥናቶች
- Columbus, OH57 ጥናቶች
- Washington, DC55 ጥናቶች
በTacoma ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር18 ጥናቶች
- አልሰራቲቭ ኮላይቲስ15 ጥናቶች
- Multiple Myeloma13 ጥናቶች
- የፕሮስቴት ካንሰር11 ጥናቶች
- የክሮን በሽታ11 ጥናቶች
- የኮሎሬክታል ካንሰር9 ጥናቶች
- Metastatic Cancer9 ጥናቶች
- ሜላኖማ7 ጥናቶች
- የእንቁላል ካንሰር7 ጥናቶች
- የሆድ ካንሰር6 ጥናቶች
- የሆድ መግቢያ ካንሰር6 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)6 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።